EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Quantitative Assessment of Upper Limb Motor Function Across Disease Stages in Hereditary Transthyretin Amyloidosis

Mehrnaz Hamedani, Valeria Prada iD, Sara Massucco, Edoardo Roveta, Marina Grandis, Chiara Gemelli, Irene Schiavetti, Alessio Signori, Cristina Schenone, Marco Luigetti, Valeria Guglielmino, Maria Ausilia Sciarrone und 14 weitere

Journal of the Peripheral Nervous System · 2026-06 · 31 (2)

DOI: 10.1111/jns.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, online erschienen am 05.06.2026. Verfasst von Mehrnaz Hamedani und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, Genova, Italy. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Upper Extremity. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ionis Pharmaceuticals Inc., AstraZeneca Pharmaceuticals, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Hereditary transthyretin amyloidosis (ATTRv) is a multisystemic disease where early neuropathy signs are challenging to detect conventionally. This study aimed to evaluate hand motor performance in ATTRv using the Hand Test System (HTS) across disease stages and examine correlations with standard measures.

Methods

A total of 113 individuals were enrolled: 74 patients with ATTRv (divided according to Familial Amyloid Polyneuropathy [FAP] stage into FAP0: pre‐symptomatic with confirmed TTR mutations, n = 16; FAP1: mild sensory/motor symptoms, n = 40; FAP2: ambulatory with assistance, n = 18) and 39 healthy controls. All participants underwent HTS evaluation; 9‐Hole Peg Test (9HPT); handgrip and tripod pinch strength testing; Thumb Opposition Test (TOT); Neuropathy Impairment Score (NIS); Disabilities of the Arm, Shoulder and Hand questionnaire (DASH); and Quality of Life Diabetic Neuropathy (Norfolk QoL‐DN) questionnaire. Group differences were analyzed with analysis of covariance and correlations with Pearson's coefficients.

Results

HTS parameters (Touch Duration, Inter‐Tapping Interval, Movement Rate) significantly differed across stages between the FAP2 and all other groups, with some parameters distinguishing the FAP1 from the control and FAP0 groups. 9HPT impairment was observed only in the FAP2 group. Grip strength showed subtle changes, especially in the right hands of the FAP1 group, while tripod pinch strength declined during advanced stages. Several HTS parameters were correlated with NIS, DASH, Norfolk QoL‐DN, and hand strength. Subclinical carpal tunnel syndrome possibly influenced early‐stage results.

Interpretation

HTS detected stage‐related motor differences in ATTRv and correlated them with standard measures, offering increased sensitivity to early neuropathic changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialUpper ExtremityHumansFemaleMaleMiddle AgedAgedHand StrengthAdultSeverity of Illness IndexDisease Progression

Stichwörter der Autor:innen

amyloidosisearly detectionmotor performanceneuropathysensitivitysensorupper limb

Autor:innen und Institutionen

  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, Genova, Italy.
  • Italian Multiple Sclerosis Foundation, AISM, Genova, Italy.
  • Fondazione "DAVID CHIOSSONE", Genova, Italy.
  • IRCCS Azienda Ospedaliera Metropolitana (AOM), Neurological Clinic, Genova, Italy.
  • Department of Health Sciences (DISSAL), University of Genova, Genova, Italy.
  • IRCCS Azienda Ospedaliera Metropolitana (AOM), Genova, Italy.

ORCID-Profile: Valeria Prada, Francesca Vitali, Luca Guglielmo Pradotto, Fiore Manganelli, Chiara Pisciotta, Davide Pareyson, Angelo Schenone

Förderung

  • Ionis Pharmaceuticals Inc.
  • AstraZeneca Pharmaceuticals
  • European Union
  • European Commission

Zitieren

APA

Hamedani, M., Prada, V., Massucco, S., Roveta, E., Grandis, M., Gemelli, C., Schiavetti, I., Signori, A., Schenone, C., Luigetti, M., Guglielmino, V., Sciarrone, M. A., Vitali, F., Pradotto, L. G., Manganelli, F., Tozza, S., Palumbo, G., Mazzeo, A., Gentile, L., …, & Schenone, A. (2026). A Quantitative Assessment of Upper Limb Motor Function Across Disease Stages in Hereditary Transthyretin Amyloidosis. Journal of the Peripheral Nervous System, 31(2). https://doi.org/10.1111/jns.70127

Vancouver

Hamedani M, Prada V, Massucco S, Roveta E, Grandis M, Gemelli C, et al. A Quantitative Assessment of Upper Limb Motor Function Across Disease Stages in Hereditary Transthyretin Amyloidosis. Journal of the Peripheral Nervous System. 2026;31(2). doi:10.1111/jns.70127

BibTeX
@article{Hamedani2026,
  author = {Hamedani, Mehrnaz and Prada, Valeria and Massucco, Sara and Roveta, Edoardo and Grandis, Marina and Gemelli, Chiara and Schiavetti, Irene and Signori, Alessio and Schenone, Cristina and Luigetti, Marco and Guglielmino, Valeria and Sciarrone, Maria Ausilia and Vitali, Francesca and Pradotto, Luca Guglielmo and Manganelli, Fiore and Tozza, Stefano and Palumbo, Giovanni and Mazzeo, Anna and Gentile, Luca and Russo, Massimo and Luca, Marcella De and D'Arma, Federica and Pisciotta, Chiara and Fenu, Silvia and Pareyson, Davide and Schenone, Angelo},
  title = {A Quantitative Assessment of Upper Limb Motor Function Across Disease Stages in Hereditary Transthyretin Amyloidosis},
  journal = {Journal of the Peripheral Nervous System},
  year = {2026},
  volume = {31},
  number = {2},
  doi = {10.1111/jns.70127}
}
Kostenlos starten →